Dermatology

Latest News

australian health care and biosimilar | Image credit: Sandor Kacso - stock.adobe.com
Paving the Way for Equitable Biosimilar Access in Australian Dermatology Clinics

May 13th 2025

Australia’s growing reliance on high-cost biologics for inflammatory skin diseases has placed significant pressure on its health system—but a new report suggests biosimilars could offer financial relief, provided uptake barriers are addressed through policy reform and education.

pharmaceutical sales data | Image credit: N F/peopleimages.com - stock.adobe.com
Samsung Bioepis Report Signals Turning Point for US Biosimilars

May 1st 2025

patient talking to doctor |  Image credit: New Africa - stock.adobe.com
Clinical Evidence Shows No Safety Gaps Between Biosimilar, Reference Adalimumab

April 26th 2025

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.